Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

Q3 2025 Earnings Call Transcript January 30, 2025 Takeshi Horikoshi: This is Horikoshi, the CFO. I will go through the ...

In an exchange filing last month, the company had informed that a meeting of its Board of Directors is scheduled for this ...

When compared on a sequential basis, Premier Energies reported a 12.2% growth in its topline, while its EBITDA grew by 35%.

For Nifty-50 index, 23,270 and 23,100 would act as key support zones, while the 50-day SMA, 23,810 and 23,900 could be the ...

Hindustan Media Ventures Ltd (HMVL) on Monday reported a consolidated profit after tax of Rs 18 crore in the December quarter ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

The EBITDA margin stood at 26% in the reporting quarter versus 23.1% YoY. The results came after the close of the market ...